article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. References 1. 8 (2018) 2. 1 (2016) 3.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. References 1. 8 (2018) 2. 1 (2016) 3.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

For example, Sanofi, Pfizer, Gilead, Novartis, BMS, Genentech, and Bayer have all announced significant alliances to integrate these big data technologies into drug discovery operations. Given the state of the field, much of the FDA guidance to date has been around the regulation of AI in medical devices.

article thumbnail

EMA unveils first projects as data partners join DARWIN EU project

pharmaphorum

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

article thumbnail

Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

Roots Analysis

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

article thumbnail

Technology Trends and Collaborations are Ushering in a New Era of ‘Pharmaceutical Intelligence’

ACRP blog

Through these collaborations, advanced technologies tied to AI and big data are being employed to develop personalized and targeted medicines, ultimately leading to more effective treatments for diseases like cancer and immune deficiencies,” Lyons notes.

article thumbnail

EMA pilot will see if clinical trial data should be digested ‘raw’

pharmaphorum

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.